NEW YORK (GenomeWeb News) – Horizon Discovery said today it has entered into a research collaboration covering gene editing with the Institute of Neurology, University College London.

The partnership will focus on creating human isogenic disease model cell lines with the insertion of Huntington disease-causing triplet repeats. The program at UCL is a new disease area for Horizon, and inserting triplet repeats into a wild type genome is a new alteration application for the company's rAAV-mediated human gene-editing platform called Genesis, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.